Literature DB >> 2707849

Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

D M Williams1, L F Bonewald, G D Roodman, G I Byrne, D M Magee, J Schachter.   

Abstract

A mouse model of pneumonia caused by murine Chlamydia trachomatis (mouse pneumonitis agent) was used to demonstrate that whole spleen cells from both nude athymic mice (nu/nu) and heterozygous mice (nu/+) produced tumor necrosis factor alpha in vitro in response to mouse pneumonitis agent antigen. The tumor necrosis factor alpha measured in these supernatants by immunoassay was shown to have bioactivity in a cytotoxic assay in which uninfected target cells were used. This cytotoxicity was distinct from the gamma interferon-related cytotoxicity against C. trachomatis-infected targets that we described previously.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707849      PMCID: PMC313281          DOI: 10.1128/iai.57.5.1351-1355.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin.

Authors:  J A Elias; R C Krol; B Freundlich; P M Sampson
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse.

Authors:  G I Byrne; B Grubbs; T J Dickey; J Schachter; D M Williams
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

3.  Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon.

Authors:  D Aderka; D Novick; T Hahn; D G Fischer; D Wallach
Journal:  Cell Immunol       Date:  1985-05       Impact factor: 4.868

4.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

6.  Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor.

Authors:  R Munker; J Gasson; M Ogawa; H P Koeffler
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

7.  Evidence for tumour necrosis factor/cachectin production in cancer.

Authors:  F Balkwill; R Osborne; F Burke; S Naylor; D Talbot; H Durbin; J Tavernier; W Fiers
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

8.  Production of tumor necrosis factor during murine listeriosis.

Authors:  E A Havell
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

9.  Importance of reinfection in the pathogenesis of trachoma.

Authors:  J T Grayston; S P Wang; L J Yeh; C C Kuo
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec

10.  Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity.

Authors:  D M Williams; J Schachter
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec
View more
  21 in total

1.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

Authors:  D J Conway; M J Holland; R L Bailey; A E Campbell; O S Mahdi; R Jennings; E Mbena; D C Mabey
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Expression of gelatinase B in trachomatous conjunctivitis.

Authors:  A M El-Asrar; K Geboes; S A Al-Kharashi; A A Al-Mosallam; L Missotten; L Paemen; G Opdenakker
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

4.  Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis.

Authors:  H Holtmann; Y Shemer-Avni; K Wessel; I Sarov; D Wallach
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Authors:  J U Igietseme; P B Wyrick; D Goyeau; R G Rank
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated.

Authors:  R R Ingalls; P A Rice; N Qureshi; K Takayama; J S Lin; D T Golenbock
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16

8.  Tumor necrosis factor alpha activity in genital tract secretions of guinea pigs infected with chlamydiae.

Authors:  T Darville; K K Laffoon; L R Kishen; R G Rank
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Tumor necrosis factor alpha, interleukin-1 alpha, interleukin-6, and prostaglandin E2 production in murine peritoneal macrophages infected with Ehrlichia risticii.

Authors:  A M van Heeckeren; Y Rikihisa; J Park; R Fertel
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.